EcoDrugPlus


Keyword(s):	Human Metabolites
Molecule Category	Free-form
UNII	QB5SR7NM49
EPA CompTox	DTXSID00222386

Keyword(s):

Human Metabolites

Molecule Category

Free-form

UNII

QB5SR7NM49

EPA CompTox

DTXSID00222386


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	NXAIQSVCXQZNRY-UHFFFAOYSA-N
Smiles	ClCS(=O)(=O)c1ccccc1
InChI	InChI=1S/C7H7ClO2S/c8-6-11(9,10)7-4-2-1-3-5-7/h1-5H,6H2

InChI Key

NXAIQSVCXQZNRY-UHFFFAOYSA-N

Smiles

ClCS(=O)(=O)c1ccccc1

InChI

InChI=1S/C7H7ClO2S/c8-6-11(9,10)7-4-2-1-3-5-7/h1-5H,6H2

Property Name	Value
Molecular Formula	C7H7Cl1O2S1
Molecular Weight	189.99
AlogP	1.66
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	2.0
Polar Surface Area	34.14
Molecular species	None
Aromatic Rings	1.0
Heavy Atoms	11.0

Property Name

Value

Molecular Formula

C7H7Cl1O2S1

Molecular Weight

189.99

AlogP

1.66

Hydrogen Bond Acceptor

2.0

Hydrogen Bond Donor

0.0

Number of Rotational Bond

2.0

Polar Surface Area

34.14

Molecular species

None

Aromatic Rings

1.0

Heavy Atoms

11.0

Resources	Reference
CAS NUMBER	7205-98-3
NORMAN SUSDAT
FDA SRS	QB5SR7NM49
PubChem	81625
ChemSpider	73654.0

Resources

Reference

CAS NUMBER

7205-98-3

NORMAN SUSDAT

FDA SRS

QB5SR7NM49

PubChem

81625

ChemSpider

73654.0


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

((CHLOROMETHYL)SULPHONYL)BENZENE

Structure

Physicochemical Descriptors

Cross References